TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Bioform AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
20,994
|
12,530
|
15,038 |
Financial expenses |
135
|
138
|
34 |
Earnings before taxes |
8,553
|
802
|
4,269 |
Total assets |
20,388
|
17,422
|
14,498 |
Current assets |
16,893
|
14,927
|
12,829 |
Current liabilities |
2,033
|
5,182
|
3,386 |
Equity capital |
18,356
|
12,241
|
11,112 |
- share capital |
691
|
740
|
718 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
90.0%
|
70.3%
|
76.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
40.7%
|
6.4%
|
28.4% |
Return on assets (ROA) |
42.6%
|
5.4%
|
29.7% |
Current ratio |
830.9%
|
288.1%
|
378.9% |
Return on equity (ROE) |
46.6%
|
6.6%
|
38.4% |
Change turnover |
9,295
|
-2,974
|
7,377 |
Change turnover % |
79%
|
-19%
|
96% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.